å»çæ©é¢ãä»è·æœèšãªã©ã®åŸæ¥è
ã§ãæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã®æ£è
ã»å
¥æè
çã«å¯Ÿå¿ããè
ã«20äžåããã®ä»ã®è
ã«ã¯5äžåãæ
°åŽéãšããŠæ¯çµŠããââã5æ27æ¥ã«é£è°æ±ºå®ããã第2次è£æ£äºç®ã§ããæ°åã³ãããŠã€ã«ã¹ææçç·æ¥å
æ¬æ¯æŽäº€ä»éãã倧å¹
ã«æ¡å
ããå»çåŸäºè
ãªã©ãžã®æ
°åŽéã®æ¯çµŠãéç¹å»çæ©é¢ãžã®æ¯æŽãªã©ãæ°ãã«ã¡ãã¥ãŒã«çã蟌ãŸããŸãããå亀ä»éã®éé¡ã¯2å
2370ååãšã第1次è£æ£äºç®ã®1490ååãã15åã«æ¡å
ãä»è·ã»é害çŠç¥ãæ°ãã«äº€ä»éã®å¯Ÿè±¡ã«ãªããŸããã
ãå»çæ©é¢ã®å»çåŸäºè ãè·å¡ã«é¢ããŠã¯ãå³1ã®ããã«é åãä»è·æœèšçã®åŸæ¥è ã«ã¯å³2ã®ããã«é åãããèŠéãã§ããéœéåºççãèšå®ããéç¹å»çæ©é¢ãCOVID-19æ£è ã®å ¥é¢ãåãå ¥ããŠããå»çæ©é¢ãåž°åœè ã»æ¥è§Šè å€æ¥ãèšçœ®ããå»çæ©é¢ãPCRæ€æ»ã»ã³ã¿ãŒãªã©ã«å€åããæ£è ãšæ¥ããå»çåŸäºè ãäºåè·å¡ã«ã¯20äžåããã®ä»ã®å»çåŸäºè ãäºåè·å¡ãªã©ã«5äžåã絊ä»ãããšãããã®ã§ãã
ãå»çæ©é¢ã®å»çåŸäºè ãè·å¡ã«é¢ããŠã¯ãå³1ã®ããã«é åãä»è·æœèšçã®åŸæ¥è ã«ã¯å³2ã®ããã«é åãããèŠéãã§ããéœéåºççãèšå®ããéç¹å»çæ©é¢ãCOVID-19æ£è ã®å ¥é¢ãåãå ¥ããŠããå»çæ©é¢ãåž°åœè ã»æ¥è§Šè å€æ¥ãèšçœ®ããå»çæ©é¢ãPCRæ€æ»ã»ã³ã¿ãŒãªã©ã«å€åããæ£è ãšæ¥ããå»çåŸäºè ãäºåè·å¡ã«ã¯20äžåããã®ä»ã®å»çåŸäºè ãäºåè·å¡ãªã©ã«5äžåã絊ä»ãããšãããã®ã§ãã